Updated Jul 16, 2026
BASKETT FOREST is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20.00M. Lifetime open-market sales: $6K. Historical track record: 5/5 stars across 3 tracked purchases.

Forest Baskett is a prominent venture capitalist and a partner at New Enterprise Associates (NEA), a leading venture capital firm. He has a strong background in technology investments and has been involved with various companies in the healthcare and technology sectors. Baskett has served on the boards of several companies, including NeueHealth, Inc., where he is currently involved as noted in the recent SEC filing.
| Role | Insider |
|---|---|
| Notability | 75/100 |
| Links | Wikipedia |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 10000% |
| 90-day win rate | 0% |
| Avg 5-day return | +842.67% |
| Avg 30-day return | +1046.29% |
| Avg 90-day return | -824.96% |
| Best 30-day return | +1393.73% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-13 | KRRO | Korro Bio, Inc. | P — Open-market purchase | 207.1K | $11.11 | $2.30M |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 402.3K | — | |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 955.0K | — | |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | P — Open-market purchase | 937.5K | $16.00 | $15.00M |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 738.0K | — | |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 1.37M | — | |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 1.37M | — | |
| 2026-02-11 | SGP | SpyGlass Pharma, Inc. | J — Other acquisition / disposition | 1.62M | — | |
| 2025-10-02 | NEUE | NeueHealth, Inc. | D — Derivative transaction | 674.6K | — | |
| 2025-10-02 | NEUE | NeueHealth, Inc. | F — Tax withholding / forfeiture | 276 | $6.75 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | M — Option exercise | 186.1K | $0.01 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | S — Open-market sale | 280 | $6.75 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | J — Other acquisition / disposition | 189.2K | $0.01 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | D — Derivative transaction | 1.16M | — | |
| 2025-10-02 | NEUE | NeueHealth, Inc. | F — Tax withholding / forfeiture | 551 | $6.75 | $4K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | M — Option exercise | 372.3K | $0.01 | $4K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | S — Open-market sale | 280 | $6.75 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | J — Other acquisition / disposition | 189.2K | $0.01 | $2K |
| 2025-10-02 | NEUE | NeueHealth, Inc. | D — Derivative transaction | 43.7K | — | |
| 2025-10-02 | NEUE | NeueHealth, Inc. | D — Derivative transaction | 1.96M | — |
Forest Baskett is a prominent venture capitalist and a partner at New Enterprise Associates (NEA), a leading venture capital firm. He has a strong background in technology investments and has been involved with various companies in the healthcare and technology sectors. Baskett has served on the boards of several companies, including NeueHealth, Inc., where he is currently invo…
Recorded transactions: 6 open-market purchases ($20.00M) and 3 open-market sales ($6K) across all tracked filings.
Across 3 tracked purchases, BASKETT FOREST averaged +1046.3% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BASKETT FOREST profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.